demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
chloroquine and derivatives
hydroxychloroquine HYDRA ...

8 studies excluded by filtering options 0

5056 Lopez, 2020 0130selection pending
5226 Duke university (Hydroxychloroquine), 2020 210excludedrisk of bias not avaialble
5267 Mahevas, 2020 1133not a RCThigh risk of bias
5350 Yu, 2020 1134not a RCThigh risk of bias
5599 Karolyi, 2020 0130selection pending
5864 HYDRA, 2020 210excludedrisk of bias not avaialble
5878 REMAP-CAP-HCQ, 2020 110risk of bias not avaialble
9243 Sarhan, 2022 010selection pending